3. Results
±
BLOOD
Participant Characteristics: LCD and LCD+INT reduced caloric intake over the intervention by design, and there was no difference between groups (−752.1 ± 230.4 vs. −422.7 ± 203.3 kcals/day; Blood Lipids and Glucose Metabolism: LCD and LCD+INT reduced cholesterol (Circulating LEAP-2: Both LCD and LCD+INT decreased fasting LEAP-2 (−3.4 ± 2.1 vs. −1.4 ± 1.4 ng/dL; Visual Analog Scale: LCD or LCD+INT tended to reduce fasted desire for sweets (17.0 ± 11.6 vs. 7.3 ± 6.9; Correlations: Higher circulating LEAP-2